GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 74 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $21,430,000 | -19.6% | 2,225,360 | -1.2% | 0.04% | -20.0% |
| Q2 2017 | $26,651,000 | +15.5% | 2,252,831 | +25.2% | 0.05% | +11.1% |
| Q1 2017 | $23,070,000 | -0.2% | 1,799,502 | -4.7% | 0.04% | -6.2% |
| Q4 2016 | $23,119,000 | -5.1% | 1,888,768 | -8.5% | 0.05% | 0.0% |
| Q3 2016 | $24,371,000 | +33.5% | 2,065,321 | -1.5% | 0.05% | +23.1% |
| Q2 2016 | $18,249,000 | +58.9% | 2,097,580 | -3.7% | 0.04% | +62.5% |
| Q1 2016 | $11,485,000 | -33.7% | 2,179,295 | -2.4% | 0.02% | -29.4% |
| Q4 2015 | $17,331,000 | -3.5% | 2,233,358 | -2.1% | 0.03% | -8.1% |
| Q3 2015 | $17,952,000 | -11.0% | 2,281,063 | +2.4% | 0.04% | 0.0% |
| Q2 2015 | $20,180,000 | -30.6% | 2,227,398 | -0.6% | 0.04% | -28.8% |
| Q1 2015 | $29,088,000 | -10.3% | 2,240,950 | -5.9% | 0.05% | -7.1% |
| Q4 2014 | $32,412,000 | +86.9% | 2,381,506 | +23.2% | 0.06% | +80.6% |
| Q3 2014 | $17,342,000 | -36.5% | 1,933,314 | -4.3% | 0.03% | -34.0% |
| Q2 2014 | $27,327,000 | +33.2% | 2,019,711 | -2.1% | 0.05% | +30.6% |
| Q1 2014 | $20,516,000 | -33.0% | 2,063,989 | -10.2% | 0.04% | -34.5% |
| Q4 2013 | $30,604,000 | +1.7% | 2,299,335 | -7.2% | 0.06% | -5.2% |
| Q3 2013 | $30,091,000 | -99.8% | 2,476,648 | +29.4% | 0.06% | +38.1% |
| Q2 2013 | $19,788,589,000 | – | 1,913,790 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|